RxDoctor Payments Data

Diana Taylor, MD

Family Medicine · Delaware, OHNPI 1295793735

Payments from drug & device makers

$1,662in general payments, 2019–2025

Across 118 payments — averaging $14.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$276
  • AstraZeneca$187
  • GSK$168
  • Novo Nordisk$154
  • Lilly USA, LLC$144
  • Pfizer$138
  • plus $594 from 14 others

What the payments were for

  • Food & beverage$1,65499%
  • Education$81%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,662 in reported general payments places this provider in the 70th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$24,623
Medicare patients
145
Services billed
479

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide57$57,055
EliquisApixaban44$52,976
TrulicityDulaglutide33$32,993
JardianceEmpagliflozin24$30,338
Trelegy ElliptaFluticasone/Umeclidin/Vilanter24$19,315
FarxigaDapagliflozin Propanediol19$18,967
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog12$10,455
Breztri AerosphereBudesonide/Glycopyr/Formoterol11$7,144
Tresiba Flextouch U-100Insulin Degludec12$5,628
Fluticasone-SalmeterolFluticasone Propion/Salmeterol40$5,249
Advair DiskusFluticasone Propion/Salmeterol22$3,884
Atorvastatin Calcium459$3,479
Gabapentin160$3,357
Metoprolol Succinate146$3,116
Lantus SolostarInsulin Glargine,hum.Rec.Anlog14$2,872

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$154$57,05557 claims
PfizerEliquis$138$52,97644 claims
Lilly USA, LLCTrulicity$144$32,99333 claims
Boehringer IngelheimJardiance$78$30,33824 claims
AstraZenecaFarxiga, Breztri Aerosphere$187$26,11130 claims
GSKTrelegy Ellipta$168$19,31524 claims
AbbVieSynthroid$276$1,47243 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Delaware

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →